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OBJECTIVE—This study was performed to understand how left ventricular function modu-
lates the prognostic importance of diabetes after myocardial infarction (MI).
RESEARCHDESIGNANDMETHODS—ConsecutivelyhospitalizedMIpatientsscreened
for three clinical trials were followed for a median of 7 years. Multivariable Cox regression models
wereusedtoassesstheriskofmortalityassociatedwithdiabetes,andtheimportanceofdiabeteswas
examined independently within deﬁned left ventricular ejection fraction (LVEF) subgroups.
RESULTS—A total of 16,912 patients were included; 1,819 (11%) had diabetes. Diabetes and
15% unit depression in LVEF were of similar prognostic importance: hazard ratios (HRs) were
1.45 (95% CI 1.37–1.54) and 1.41 (1.37–1.45) for diabetes and LVEF depression, respectively.
LVEF modiﬁed the outcomes associated with diabetes, with HRs being 1.29 (1.19–1.40) and
1.61 (1.49–1.74) in patients with LVEF ,40% and LVEF $40%, respectively (P = 0.03).
CONCLUSIONS—Patients within the higher LVEF categories have a greater mortality risk
attributable to diabetes than patients within the lower LVEF categories.
Diabetes Care 34:1788–1790, 2011
D
iabetic patients without myocardial
infarction (MI) and MI patients
without diabetes have a high and
equally adverse long-term risk of cardio-
vascular death compared with the general
population (1,2). As well as diabetes, the
presenceofsystolicdysfunctionandheart
failure are major risk factors for mortality
after MI. A recent study suggested that
diabetes may be regarded as a risk equiv-
alent to low left ventricular ejection frac-
tion (LVEF) and that ordinary LVEF risk
stratiﬁcation may notbe valid in these pa-
tients (3). This study was performed to
further clarify their interrelationship.
RESEARCH DESIGN AND
METHODS—The current study pop-
ulation comprised Danish patients
consecutively screened for entrance in the
Trandolapril Cardiac Evaluation (TRACE)
study (4), the Danish Investigations of
Arrhythmia and Mortality on Dofetilide
Myocardial Infarction (DIAMOND-MI)
study (5), and the Bucindolol Evaluation
in Acute MI Trial (BEAT) study (6). Full
study designs have been described previ-
ously (4–6). In brief, departments partici-
pating in any of the studies were required
to screen consecutive patients admitted
with acute MI. All screenings included a
transthoracic echocardiogram, which was
analyzed in a core laboratory by indepen-
dent investigators. LVEF was estimated
through a global wall motion index, a
nine-segmentmodelintheTRACEstudy
(7), and a 16-segment model in the
DIAMOND-MI and BEAT studies (8).
This way of obtaining LVEF has a good
correlation with outcomes (7).
All comorbidities including the di-
agnosis of diabetes were by patient his-
tory, patient ﬁles, and investigator’s
determination. The outcome analyzed
was the risk of all-cause mortality. Sur-
vival status was obtained from the Na-
tional Population Register on 28 May
2008, giving a maximal observational
time of 18 years.
Statistical analysis
Continuous variables were compared
with a t test and discrete variables with
the x
2 test. Cox proportional hazards
models were used for analyses of mortal-
ityrates.Allmodelswereadjustedforage,
sex, LVEF, chronic obstructive pulmo-
nary disease, hypertension, presence of
clinical heart failure, a variable indicating
the wall motion index scoring system
(9 vs. 16 segments), and calendar year of
hospitalization. Test for interaction be-
tween LVEF and diabetes was done by in-
clusion of an interaction term in the Cox
model with LVEF included as a continu-
ous variable. The relative importance of
diabetes was examined independently in
patients within deﬁned groups according
to LVEF. All analyses were done using
SASversion9.1(SASInstitute,Cary,NC).
Ethics
All studies were approved by the relevant
ethical committees and were conducted
in conformity with the Declaration of
Helsinki.
RESULTS—A total of 16,912 patients
were included in the present analysis. Pa-
tients with diabetes were found to be older
(69 6 11 [SD] vs. 67 6 12 years), have a
lower LVEF (41 6 12 vs. 45 6 12%), a
higher frequency of women (38 vs.
30%), a higher prevalence of clinical heart
failure (62 vs. 44%), lower creatinine
clearance (69 6 1v s .7 26 1m L / m i n /
1.73 m
2), and higher BMI (26.9 6 0.1
vs. 25.9 6 0.1 kg/m
2) than patients with-
out diabetes.
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BRIEF REPORTDuring a median observational time
of 2,609 days (interquartile range 820–
3,937), 1,396 (77%) patients with diabe-
tes and 8,985 (60%) patients without
diabetes died, respectively. Figure 1 pres-
ents the unadjusted mortality rates for
some given intervals of LVEF in patients
with and without diabetes. Decreasing
LVEF subgroup was associated with in-
creasing hazard ratios (HRs) (adjusted
for age, sex, wall motion index analysis
method, and calendar year): 1.02 (0.81–
1.27), 1.46 (1.34–1.60), 1.84 (1.64–
2.06), and 1.61 (1.44–1.80) in the LVEF
,25%, LVEF 25–35%, LVEF 36–50%,
and LVEF .50% subgroups, respec-
tively. In multivariable Cox analysis, di-
abetesanda15%unitdepressioninLVEF
were found to be of similar prognostic
importance: HRs 1.45 (95% CI 1.37–
1.54) and 1.41 (1.37–1.45) for diabetes
and LVEF depression, respectively. The
prognostic importance of diabetes was
modulated by LVEF; P for interaction be-
tween diabetes and LVEF = 0.03. Among
patientswithlowLVEF(,40%),diabetes
wasassociatedwithHR1.29(1.19–1.40),
which corresponded to the importance
of having 10% unit depression in LVEF
(HR 1.26 [1.24–1.28] in the overall anal-
ysis). Among patients with a high LVEF
($40%),diabeteswasassociatedwithHR
of 1.61 (1.49–1.74) and was of similar
prognostic importance as 20% unit de-
pression in LVEF (HR 1.58 [1.53–1.64]).
CONCLUSIONS—This study demon-
strated that the prognostic importance of
diabetes depends on left ventricular func-
tion, with diabetes having a stronger neg-
ative inﬂuence with preserved ventricular
function. This result was also found in an-
other study (3) and may appear counter-
intuitive given the detrimental inﬂuence
of diabetes in patients with heart failure
(9).However,therelationship between di-
abetes and heart failure is bidirectional,
and diabetes may not always contribute
causally to the adverse prognosis. For ex-
ample, it is known that a great proportion
ofpatientswithsevereheartfailurewillde-
velop diabetes over time (10).
Other studies have in accordance
with our ﬁnding reported the risk of dy-
ing from diabetes after MI to be greatest
among patientswithlowest baseline mor-
tality risk (11) and among patients with
mildest coronary artery lesions (12). In
our study, diabetes was associated with
a60%increaseinrelativerisk ofmortality
among patients with preserved LVEF.
Although in the current study it was im-
possible to investigate what exactly may
have driven this increase in risk, compli-
cations such as incident heart failure are
common over time and are associated
with a poor prognosis (13,14).
Finally, as previously reported (3),
the protective effect on mortality associ-
ated with good left ventricular function
after MI was found to be attenuated by
diabetes, with diabetes conferring a risk
equivalent to 10–20% unit depression in
LVEF. With regards to prognostic strati-
ﬁcation, this is clinically important be-
cause predischarge assessment of LVEF
should be interpreted differently in pa-
tients with diabetes.
Limitations
The diagnosis of diabetes relied on patient
history, and oral glucose tolerance tests
were not performed on a routine basis.
LVEF was estimated by wall motion index,
which is observer-dependent and an ap-
proximation of LVEF. The current study
did not have information on diabetes du-
ration,HbA1c values,incidentdiabetes,use
of glucose-lowering agents, or diastolic
function, which may have inﬂuenced out-
comes. Finally, the subgroup of patients
with LVEF ,25% was small; therefore, a
small true increase in HR associated with
diabetes cannot be excluded.
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